Budget Amount *help |
¥18,850,000 (Direct Cost: ¥14,500,000、Indirect Cost: ¥4,350,000)
Fiscal Year 2010: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2009: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2008: ¥6,630,000 (Direct Cost: ¥5,100,000、Indirect Cost: ¥1,530,000)
|
Research Abstract |
Body weight loss and appetite loss are specificically observed after upper digestive tract surgery including carcinomas of the stomach and esophagus, and strongly impaired post operative QOL. We have performed randomized clinical trial and proved that administration of synthetic ghrelin, a novel gastrointestinal hormone, successfully improved these symptoms. The clinical application of ghrelin is promising for these patients.
|